Shares of cannabis stocks continued their rally Tuesday, after President Donald Trump a day earlier said he was “very strongly” weighing an executive order to reschedule the drug.

In December, President Donald Trump in an executive order told his attorney general to expediate a rulemaking process related to rescheduling marijuana as a less-dangerous drug.

Cannabis stocks rebound as U.S. President Donald Trump is expected to issue an executive order on marijuana rescheduling as early as Wednesday. Read more here.

Pot stocks Trulieve Cannabis, Curaleaf, Cresco Labs, Green Thumb Industries, and Canopy Growth plummeted by up to 39% due to ...

Cannabis stocks slid as Trump prepares to sign an executive order to reclassify marijuana as less dangerous. Read more here.

Tilray's beverage business now generates $241 million annually, nearly matching its $249 million in cannabis revenue. Canopy Growth narrowed its adjusted EBITDA loss to 7.9 million Canadian dollars ...

Cannabis stocks rally following fresh reports that President Trump is poised to reschedule marijuana to Schedule III.

With marijuana legalized in Canada, these stocks offer direct exposure and could help you get a piece of the pot.

Cannabis stocks have crashed in recent years, and they have made for abysmal investments. Potential reform in the industry could open up new growth opportunities and bring down expenses for companies.

U.S. and Canadian names rally. But one expert notes 'the rescheduling process has faced many hurdles in the past.' Shares of Tilray jumped more than 27% on Tuesday. Shares of U.S. and Canadian ...

Shares of U.S. and Canadian cannabis stocks continued their rally on Tuesday, after President Donald Trump a day earlier said he was “very strongly” weighing an executive order to reschedule the drug ...